Flucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: A randomised controlled trial

Emergency Medicine Journal

Volumn 22, Issue 5, 2005, Pages 342-346

  Leman, Peter ^a,b   Mukherjee, D ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; FLUCLOXACILLIN; PENICILLIN G;

ADULT; ARTICLE; AUSTRALIA; BODY TEMPERATURE; CELLULITIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENERAL CONDITION IMPROVEMENT; HOSPITAL ADMISSION; HUMAN; LEG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TEACHING HOSPITAL; VISUAL ANALOG SCALE;

ADULT; ANTI-BACTERIAL AGENTS; CELLULITIS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLOXACILLIN; HUMANS; LEG; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; PENICILLIN G; TREATMENT OUTCOME;

EID: 18744391720     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2004.019869     Document Type: Article

References (28)

1. Anonymous. Dilemmas when managing cellulitis. Drug Ther Bull 2003;41:43-6.
2. Gentry LR-GG, Zeluff BJ, Khoshdel A, et al. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections. Am J Infect 1989;87:57-60S.
3. Department of Health. Hospital episode statistics for England, 2001-2. www.doh.gov.uk/hes/free⊣ta/index.html. Last accessed 15 November, 2003.
4. Grayson ML, Silvers J, Turnidge J. Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care. Med J Aust 1995;162:249-53.
5. Leder K, Turnidge JD, Grayson ML. Home-based treatment of cellulitis with twice-daily cefazolin. Med J Aust 1998; 169:519-22.
6. Bernard P, Chosidow O, Vaillant L. Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial. BMJ 2002;325:864.
7. Siami G, Christou N, Eiseman I, et al. Clinafloxacin versus piperacillintazobactam in treatment of atients with severe skin and soft tissue infections. Antimicrob Agents Chemother 2001;45:525-31.
8. Grayson ML, McDonald M, Gibson K, et al. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults. Clin Infect Dis 2002; 34:1440-8.
9. Bucko AD, Hunt BJ, Kidd SL, et al. Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections. Clin Ther 2002;24:1134-47.
10. Dong SL, Kelly KD, Oland RC, et al. ED management of cellulitis: a review of five urban centers. Am J Emerg Med 2001;19:535-40.
11. Aly AA, Roberts NM, Seipol KS, et al. Case survey of management of cellulitis in a tertiary teaching hospital. Med J Aust 1996;165:553-6.
12. Cox NH. Management of lower leg cellulitis. Clin Med 2002;2:23-7.
13. Medical Association and the Royal Pharmaceutical Society of Great Britain. British national formulary, 46th ed, 2003. www.bnf.org/bnf/bnf/current/doc/102045.htm. Last accessed 15 November 2003.
14. Morris A. Cellulitis and erysipelas. Clin Evid 2002;7:1483-7. Update in: Clin Evid 2003;9:1804-9.
15. Health Protection Agency. Management of infection guidance for primary care for consultation & local adaptation. London: HPA, 2002. www.hpa.org.uk/infections/topics_az /antibiotic_guidance/ antibiotic_guidance_290404.pdf. Last accessed 15 November, 2003.
16. Sutherland RCE, Rolinson GN. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin. BMJ 1970;4:455-60.
17. Rolinson GNSR. Semi-synthetic penicillins. Adv Pharmacol Chemother 1973;11:151-220.
18. Hepburn MJ, Dooley DP, Ellis MW. Alternative diagnoses that often mimic cellulitis. Am Fam Physician 2003;67:2471.
19. Quartey-Papofio CM. Lesson of the week: importance of distinguishing between cellulitis and varicose eczema of the leg. BMJ 1999;318:1672-3.
20. Dupuy A, Benchikhi H, Roujeau JC, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999;318:1591-4.
21. Vaillant L. (Diagnostic criteria for erysipelas). Ann Dermatol Venereol 2001;128:326-33.
22. Eriksson B, Jorup-Ronstrom C, Karkkonen K, et al. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis 1996;23:1091-8.
23. Gach JE, Charles-Holmes R, Ghose A. E. coli cellulitis. Clin Exp Dermatol 2002;27:523-5.
24. Lee NH, Choi EH, Lee WS, et al. Tuberculous cellulitis. Clin Exp Dermatol 2000;25:222-3.
25. Perl B, Gottehrer NP, Raveh D, et al. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis 1999;29:1483-8.
26. Ramirez-Ronda CHSS, Rivera-Vazquez CR. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin stuctrue infections. Am J Med 1987;82:220-3.
27. Kiani R. Double-blind, double dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections. Eur J Clin Microbiol Infect Dis 1991;10:880-4.
28. Howden BP, Richards MJ. The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis. J Antimicrob Chemother 2001; 48:311-14.